ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Astellas Pharma on track to 25% profit increase

TOKYO -- Astellas Pharma said Monday it expects a 25% increase in net profit this fiscal year to 170 billion yen ($1.4 billion), citing brisk U.S. sales.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more